Exciting Developments in the Pipeline in HER2+ MBC
A multidisciplinary panel of health care professionals and a patient advocate comment on their excitement about novel therapies in the pipeline for HER2-positive metastatic breast cancer.
HER2+ MBC: Radiation Necrosis Vs Disease Progression
Improvements regarding the identification and management of radiation necrosis in patients with HER2-positive metastatic breast cancer.
Radiation and Systemic Therapy for HER2+ Breast Cancer and Brain Metastases
Variables that impact decisions to treat HER2-positive breast cancer and brain metastases with radiation therapy and systemic therapy, and recommendations on using memantine following radiation therapy.
Talking With Patients About HER2+ MBC Treatment Options
Recommendations for deciding what information is most important to discuss with patients during initial treatment planning for HER2-positive metastatic breast cancer.
Radiation Therapy for HER2+ De Novo MBC
Radiation oncologist Kamran Ahmed, MD, comments on indications for using radiation therapy to treat patients with HER2-positive de novo metastatic breast cancer.
HER2+ Metastatic Breast Cancer Treatment Advances
A discussion regarding treatment advances in HER2-positive metastatic breast cancer, a heterogeneous disease.
2 Clarke Drive Cranbury, NJ 08512